MedWatch

Deborah Dunsire beats Novo Nordisk CEO in salary comparison

The list of the highest paid CEOs on OMX Copenhagen 25 has seen a shake-up, as former lead Lars Fruergaard Jørgensen, CEO of Novo Nordisk, has been overtaken by Deborah Dunsire, CEO of Lundbeck, and her million-dollar salary last year.

Deborah Dunsire, CEO of Lundbeck | Photo: Gregers Tycho/ERH

A new person has ascended to the throne among the best paid CEOs on OMX Copenhagen 25 (C25). Deborah Dunsire, CEO of Lundbeck, received a salary package of DKK 60.8m (USD 9.3m) in compensation for her work last year.

She overtook Lars Fruergaard Jørgensen, the CEO of Denmark’s largest pharmaceutical company, Novo Nordisk, who received a total salary package of DKK 58.3m (USD 8.9m), writes Danish business daily Børsen, which has ranked the CEOs by the C25 index companies’ remuneration reports.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs